An Essential Role for SHARPIN in the Regulation of Caspase 1 Activity in Sepsis

Madalina Viviana Nastase, Jinyang Zeng-Brouwers, Helena Frey, Louise Tzung Harn Hsieh, Chiara Poluzzi, Janet Beckmann, Nina Schroeder, Josef Pfeilschifter, Jaime Lopez-Mosqueda, Jan Mersmann, Fumiyo Ikeda, Renato V. Iozzo, Ivan Dikic, Liliana Schaefer

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Sepsis is burdened by high mortality due to uncontrolled inflammatory response to pathogens. Increased caspase 1 activation causing maturation of IL1β/18 remains a therapeutic challenge in sepsis. SHARPIN (shank-associated regulator of G-protein signaling homology domain-interacting protein), a component of the LUBAC (linear ubiquitin chain-assembly complex), regulates inflammation, with unknown effects on caspase 1 activation. Mice lacking Casp1, Casp11, or both in a Sharpin-deficient background were generated, exposed to lipopolysaccharide-induced endotoxemia, and injected with caspase 1 inhibitor. We monitored survival, Il1β/18, and caspase 1/11 levels in plasma and organs and deciphered mechanisms of SHARPIN-dependent caspase 1 inhibition. A correlation between LUBAC and active caspase 1 was found in blood mononuclear cells from septic patients. SHARPIN bound caspase 1 and disrupted p20/p10 dimer formation, the last step of caspase 1 processing, thereby inhibiting enzyme activation and maturation of IL1β/18 in a LUBAC-independent manner. In septic patients, LUBAC-independent decline in SHARPIN correlated with enhancement of active caspase 1 in circulating mononuclear cells. Septic Sharpin-deficient mice displayed enrichment in mature Il1β/18 and active caspase 1, and shortened survival. Inhibition of caspase 1 reduced levels of Il1β/18 and splenic cell death, and prolonged survival in septic Sharpin-deficient mice. Our findings identify SHARPIN as a potent in vivo caspase 1 inhibitor and propose the caspase 1-SHARPIN interaction as a target in sepsis.

Original languageEnglish
Pages (from-to)1206-1220
Number of pages15
JournalAmerican Journal of Pathology
Volume186
Issue number5
DOIs
Publication statusPublished - May 1 2016

Fingerprint

Caspase 1
Sepsis
Ubiquitin
Survival
GTP-Binding Protein Regulators
Enzyme Activation
Endotoxemia
Lipopolysaccharides
Blood Cells
Cell Death

All Science Journal Classification (ASJC) codes

  • Pathology and Forensic Medicine

Cite this

Nastase, M. V., Zeng-Brouwers, J., Frey, H., Hsieh, L. T. H., Poluzzi, C., Beckmann, J., ... Schaefer, L. (2016). An Essential Role for SHARPIN in the Regulation of Caspase 1 Activity in Sepsis. American Journal of Pathology, 186(5), 1206-1220. https://doi.org/10.1016/j.ajpath.2015.12.026

An Essential Role for SHARPIN in the Regulation of Caspase 1 Activity in Sepsis. / Nastase, Madalina Viviana; Zeng-Brouwers, Jinyang; Frey, Helena; Hsieh, Louise Tzung Harn; Poluzzi, Chiara; Beckmann, Janet; Schroeder, Nina; Pfeilschifter, Josef; Lopez-Mosqueda, Jaime; Mersmann, Jan; Ikeda, Fumiyo; Iozzo, Renato V.; Dikic, Ivan; Schaefer, Liliana.

In: American Journal of Pathology, Vol. 186, No. 5, 01.05.2016, p. 1206-1220.

Research output: Contribution to journalArticle

Nastase, MV, Zeng-Brouwers, J, Frey, H, Hsieh, LTH, Poluzzi, C, Beckmann, J, Schroeder, N, Pfeilschifter, J, Lopez-Mosqueda, J, Mersmann, J, Ikeda, F, Iozzo, RV, Dikic, I & Schaefer, L 2016, 'An Essential Role for SHARPIN in the Regulation of Caspase 1 Activity in Sepsis', American Journal of Pathology, vol. 186, no. 5, pp. 1206-1220. https://doi.org/10.1016/j.ajpath.2015.12.026
Nastase MV, Zeng-Brouwers J, Frey H, Hsieh LTH, Poluzzi C, Beckmann J et al. An Essential Role for SHARPIN in the Regulation of Caspase 1 Activity in Sepsis. American Journal of Pathology. 2016 May 1;186(5):1206-1220. https://doi.org/10.1016/j.ajpath.2015.12.026
Nastase, Madalina Viviana ; Zeng-Brouwers, Jinyang ; Frey, Helena ; Hsieh, Louise Tzung Harn ; Poluzzi, Chiara ; Beckmann, Janet ; Schroeder, Nina ; Pfeilschifter, Josef ; Lopez-Mosqueda, Jaime ; Mersmann, Jan ; Ikeda, Fumiyo ; Iozzo, Renato V. ; Dikic, Ivan ; Schaefer, Liliana. / An Essential Role for SHARPIN in the Regulation of Caspase 1 Activity in Sepsis. In: American Journal of Pathology. 2016 ; Vol. 186, No. 5. pp. 1206-1220.
@article{a699551e1d4445b4af7a8887f2b506cc,
title = "An Essential Role for SHARPIN in the Regulation of Caspase 1 Activity in Sepsis",
abstract = "Sepsis is burdened by high mortality due to uncontrolled inflammatory response to pathogens. Increased caspase 1 activation causing maturation of IL1β/18 remains a therapeutic challenge in sepsis. SHARPIN (shank-associated regulator of G-protein signaling homology domain-interacting protein), a component of the LUBAC (linear ubiquitin chain-assembly complex), regulates inflammation, with unknown effects on caspase 1 activation. Mice lacking Casp1, Casp11, or both in a Sharpin-deficient background were generated, exposed to lipopolysaccharide-induced endotoxemia, and injected with caspase 1 inhibitor. We monitored survival, Il1β/18, and caspase 1/11 levels in plasma and organs and deciphered mechanisms of SHARPIN-dependent caspase 1 inhibition. A correlation between LUBAC and active caspase 1 was found in blood mononuclear cells from septic patients. SHARPIN bound caspase 1 and disrupted p20/p10 dimer formation, the last step of caspase 1 processing, thereby inhibiting enzyme activation and maturation of IL1β/18 in a LUBAC-independent manner. In septic patients, LUBAC-independent decline in SHARPIN correlated with enhancement of active caspase 1 in circulating mononuclear cells. Septic Sharpin-deficient mice displayed enrichment in mature Il1β/18 and active caspase 1, and shortened survival. Inhibition of caspase 1 reduced levels of Il1β/18 and splenic cell death, and prolonged survival in septic Sharpin-deficient mice. Our findings identify SHARPIN as a potent in vivo caspase 1 inhibitor and propose the caspase 1-SHARPIN interaction as a target in sepsis.",
author = "Nastase, {Madalina Viviana} and Jinyang Zeng-Brouwers and Helena Frey and Hsieh, {Louise Tzung Harn} and Chiara Poluzzi and Janet Beckmann and Nina Schroeder and Josef Pfeilschifter and Jaime Lopez-Mosqueda and Jan Mersmann and Fumiyo Ikeda and Iozzo, {Renato V.} and Ivan Dikic and Liliana Schaefer",
year = "2016",
month = "5",
day = "1",
doi = "10.1016/j.ajpath.2015.12.026",
language = "English",
volume = "186",
pages = "1206--1220",
journal = "American Journal of Pathology",
issn = "0002-9440",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - An Essential Role for SHARPIN in the Regulation of Caspase 1 Activity in Sepsis

AU - Nastase, Madalina Viviana

AU - Zeng-Brouwers, Jinyang

AU - Frey, Helena

AU - Hsieh, Louise Tzung Harn

AU - Poluzzi, Chiara

AU - Beckmann, Janet

AU - Schroeder, Nina

AU - Pfeilschifter, Josef

AU - Lopez-Mosqueda, Jaime

AU - Mersmann, Jan

AU - Ikeda, Fumiyo

AU - Iozzo, Renato V.

AU - Dikic, Ivan

AU - Schaefer, Liliana

PY - 2016/5/1

Y1 - 2016/5/1

N2 - Sepsis is burdened by high mortality due to uncontrolled inflammatory response to pathogens. Increased caspase 1 activation causing maturation of IL1β/18 remains a therapeutic challenge in sepsis. SHARPIN (shank-associated regulator of G-protein signaling homology domain-interacting protein), a component of the LUBAC (linear ubiquitin chain-assembly complex), regulates inflammation, with unknown effects on caspase 1 activation. Mice lacking Casp1, Casp11, or both in a Sharpin-deficient background were generated, exposed to lipopolysaccharide-induced endotoxemia, and injected with caspase 1 inhibitor. We monitored survival, Il1β/18, and caspase 1/11 levels in plasma and organs and deciphered mechanisms of SHARPIN-dependent caspase 1 inhibition. A correlation between LUBAC and active caspase 1 was found in blood mononuclear cells from septic patients. SHARPIN bound caspase 1 and disrupted p20/p10 dimer formation, the last step of caspase 1 processing, thereby inhibiting enzyme activation and maturation of IL1β/18 in a LUBAC-independent manner. In septic patients, LUBAC-independent decline in SHARPIN correlated with enhancement of active caspase 1 in circulating mononuclear cells. Septic Sharpin-deficient mice displayed enrichment in mature Il1β/18 and active caspase 1, and shortened survival. Inhibition of caspase 1 reduced levels of Il1β/18 and splenic cell death, and prolonged survival in septic Sharpin-deficient mice. Our findings identify SHARPIN as a potent in vivo caspase 1 inhibitor and propose the caspase 1-SHARPIN interaction as a target in sepsis.

AB - Sepsis is burdened by high mortality due to uncontrolled inflammatory response to pathogens. Increased caspase 1 activation causing maturation of IL1β/18 remains a therapeutic challenge in sepsis. SHARPIN (shank-associated regulator of G-protein signaling homology domain-interacting protein), a component of the LUBAC (linear ubiquitin chain-assembly complex), regulates inflammation, with unknown effects on caspase 1 activation. Mice lacking Casp1, Casp11, or both in a Sharpin-deficient background were generated, exposed to lipopolysaccharide-induced endotoxemia, and injected with caspase 1 inhibitor. We monitored survival, Il1β/18, and caspase 1/11 levels in plasma and organs and deciphered mechanisms of SHARPIN-dependent caspase 1 inhibition. A correlation between LUBAC and active caspase 1 was found in blood mononuclear cells from septic patients. SHARPIN bound caspase 1 and disrupted p20/p10 dimer formation, the last step of caspase 1 processing, thereby inhibiting enzyme activation and maturation of IL1β/18 in a LUBAC-independent manner. In septic patients, LUBAC-independent decline in SHARPIN correlated with enhancement of active caspase 1 in circulating mononuclear cells. Septic Sharpin-deficient mice displayed enrichment in mature Il1β/18 and active caspase 1, and shortened survival. Inhibition of caspase 1 reduced levels of Il1β/18 and splenic cell death, and prolonged survival in septic Sharpin-deficient mice. Our findings identify SHARPIN as a potent in vivo caspase 1 inhibitor and propose the caspase 1-SHARPIN interaction as a target in sepsis.

UR - http://www.scopus.com/inward/record.url?scp=84964048156&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84964048156&partnerID=8YFLogxK

U2 - 10.1016/j.ajpath.2015.12.026

DO - 10.1016/j.ajpath.2015.12.026

M3 - Article

C2 - 26968342

AN - SCOPUS:84964048156

VL - 186

SP - 1206

EP - 1220

JO - American Journal of Pathology

JF - American Journal of Pathology

SN - 0002-9440

IS - 5

ER -